secwatch.observer — SEC 8-K summary
======================================

Issuer:     Peak Bio, Inc. (—)
CIK:        0001834645
Form:       8-K
Filed at:   2024-07-24T23:59:59+00:00
Accession:  0000950170-24-086110
Event type: leadership
Sentiment:  negative
Materiality: 0.80
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Three Peak Bio directors resign; board reduced to three members
---------------------------------------------------------------

- David Rosenberg, Michael Friedman, and Stephen LaMond resigned from Peak Bio's Board on July 19, 2024, effective immediately.
- Resignations for personal reasons; no disagreements with Company operations, policies, or practices.
- Board size reduced from six to three members following the departures.
- Stephen LaMond remains Interim CEO despite resigning as a director.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1834645/000095017024086110/0000950170-24-086110-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1834645/000095017024086110/pkbo-20240719.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-086110

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer